ICD-10 Coding for HLA-B27 Positive(H20.01U, H20.9I, M46.1)
Learn about the ICD-10 coding for HLA-B27 positive, including documentation requirements, clinical validation, and common coding pitfalls.
Complete code families applicable to HLA-B27 Positive
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z15.89 | Genetic susceptibility to other disease | Use when HLA-B27 positivity is documented without active disease. |
|
| M45 | Ankylosing spondylitis | Use when ankylosing spondylitis is diagnosed with HLA-B27 positivity. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHLA-B27 Positive
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting HLA-B27 Positive.
Omitting Z15.89 when HLA-B27 supports a chronic condition
Impact
Clinical: Incomplete clinical picture of genetic risk., Regulatory: Potential non-compliance with coding standards., Financial: Missed opportunities for appropriate reimbursement.
Mitigation
Review coding guidelines for genetic susceptibility, Ensure linkage between HLA-B27 and diagnosed conditions
Using R76.8 instead of Z15.89 for HLA-B27 positivity
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Misrepresentation of patient genetic status.
Mitigation
Use Z15.89 for genetic susceptibility, not R76.8.
Genetic susceptibility coding
Impact
Incorrect use of Z15.89 without proper documentation.
Mitigation
Ensure all genetic tests are linked to clinical findings or family history.